Atcor Medical Holdings Ltd (ACG.AX) Company Profile | Reuters.com
Edition:
United States

Profile: Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

0.12AUD
30 Jun 2016
Change (% chg)

$0.00 (+4.17%)
Prev Close
$0.12
Open
$0.12
Day's High
$0.12
Day's Low
$0.12
Volume
18,031
Avg. Vol
146,424
52-wk High
$0.34
52-wk Low
$0.11

Atcor Medical Holdings Limited offers medical devices for use in cardiovascular management. The Company's segments are the Americas, which includes global pharmaceutical trials business; Europe, which includes the Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. It offers SphygmoCor technology products, such as SphygmoCor XCEL PWA, SphygmoCor XCEL PWV, SphygmoCor cardiovascular management system (CVMS) CP, and others. Its SphygmoCor XCEL provides measurement of central blood pressure or pulse wave velocity; augmentation index and augmented pressure to assess peripheral arterial stiffness. Its SphygmoCor CVMS is a portable device used to non-invasively obtain cardiovascular data. SphygmoCor CVMS products include SphygmoCor CP System, SphygmoCor CPV System and others. It offers SphygmoCor Continuous Monitoring (CM) system, which provides continuous and real time, beat-to-beat central pressure waveform data and other key cardiovascular parameters.

Company Address

Atcor Medical Holdings Ltd

U 11 1059 Victoria Rd
SYDNEY   NSW   2114

Company Web Links